Elanco to sell aqua business to Merck for $1.3B
Elanco Animal Health said it has agreed to sell its aqua business to Merck Animal Health, a move that allows it to pay down some of its debt load and invest in new pipeline products.
Life Science & Biotech
Articles
BioCrossroads names Vince Wong as new CEO of Indy life sciences group
Wong’s appointment comes just a few weeks after BioCrossroads released a report warning that Indiana’s life-science sector is starting to lag the nation in growth and market share and will require a focused effort to stay competitive.
Lilly’s soaring stock, Fishers’ innovation park among top 10 life sciences stories of 2023
It was a busy year for the Indiana life sciences community, with a flurry of billion-dollar deals, major announcements, and a few setbacks. Here we present the top 10 stories of 2023—the good, the bad and the ugly—about an industry that is often hailed as a key driver of Indiana’s economy.
Carmel firm raises $116M to advance anti-inflammatory drugs into human testing
The investment in Sudo Biosciences, a three-year-old Carmel biotech, is one of the largest in recent years for an Indiana-based science startup, a signal that investors are attracted by its work on a class of drugs to treat autoimmune and inflammatory diseases.
Baxter sells Bloomington plant with 1,000 workers to private investors
The Bloomington plant, with about 1,000 employees, is the fifth-largest employer in Monroe County, according to the Greater Bloomington Chamber of Commerce, and is poised for more growth.
Lilly to build $2.5B factory in Germany for injectable drugs
The announcement represents the company’s latest move to meet the soaring demand for its medicines for diabetes and weight loss.
Carmel sanitizing device maker 3Oe Scientific files for bankruptcy
The business makes a hand-sanitizing device called Iggy that kills pathogens with ozone-infused water instead of soap or other chemicals.
Indianapolis-based life sciences research firm Pearl Pathways acquired by Versiti
The acquisition is the second in central Indiana this year for Versiti, a not-for-profit specializing in blood-health services.
Life science boosters hail Indiana’s designation as federal technology hub
The federal designation marks Indiana as a hub for biologics manufacturing. Biologics are medicines derived from biological sources and include vaccines, monoclonal antibodies, and immune modulators.
UPDATE: Feds pick Indiana as biotech hub, putting it in running for millions in funding
The technology hub designation makes Indiana eligible to compete against 30 other designated hubs in hopes of landing up to $70 million in federal funding to implement its program.
Biotech firm nearing completion of Indy radioisotopes factory
Following a $45 million renovation, RayzeBio plans to use the plant to make Actinium 225, a radioisotope used for targeted therapy for cancer.
Israeli pharmaceutical company to build $20M facility in Westfield
Isotopia USA, the newly formed U.S. subsidiary of Isotopia Molecular Imaging, announced Monday that it will hire 50 people to produce a radioactive medical isotope used in pharmaceuticals for targeted cancer treatment.
Indiana’s health-care sector to shine at Rally innovation conference
With the new multimillion-dollar conference that kicks off on Tuesday, Indiana is trying to position itself as a globally known innovation hub. And health care will figure prominently on the agenda.
Carmel startup NeurAxis raises $6.6M in IPO, less than half of its original forecast
The company, which is developing electrical-nerve stimulation therapies for children, went public this month at an initial price of $6 a share—lower than the range of $7 to $9 a share it announced in February.
Fishers-based biosciences firm Quantigen acquired by Versiti
Quantigen employs 46 people at its office at 10300 Kincaid Drive, and it will retain its name following the deal.
Eli Lilly to acquire Massachusetts-based biotech for $309M
The Indianapolis-based drugmaker said it will acquire Sigilon Therapeutics Inc., a six-year-old startup that is developing a technology to help type 1 diabetes patients restore insulin production over sustained periods.
Thermo Fisher Scientific opens $6 million lab complex in Fishers
In the health care world, Thermo Fisher Scientific operates mostly behind the scenes, supplying labs and hospitals with scientific instruments, chemical ingredients and software services.
Corteva, two other companies reach $1.2B settlement over ‘forever chemicals’ in water
The pollutants, polyfluoroalkyl and perfluoroalkyl substances—commonly known as PFAS—can be found in many industrial and cosmetic products and have been linked to infertility, thyroid disorders and several types of cancer.
IBJ Podcast: Indiana becoming garden spot for vital ag innovation, food security
Host Mason King talks with AgriNovus chief Mitch Frazier, who has one of the most expansive and rounded perspectives of agricultural innovation in the state, details how Indiana is becoming a major player in vital issues of food security.
Noblesville-based Helmer Scientific acquired by Trane Technologies
Helmer Scientific, which makes temperature-controlled storage equipment for hospitals, labs, blood banks, and pharmacies, was founded in Noblesville in 1977 and has more than 400 employees.